| Product Code: ETC7656944 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neurocutaneous Syndromes Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neurocutaneous Syndromes Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neurocutaneous Syndromes Market - Industry Life Cycle |
3.4 Israel Neurocutaneous Syndromes Market - Porter's Five Forces |
3.5 Israel Neurocutaneous Syndromes Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Neurocutaneous Syndromes Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Neurocutaneous Syndromes Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Neurocutaneous Syndromes Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Neurocutaneous Syndromes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurocutaneous syndromes in Israel |
4.2.2 Advancements in diagnostic technologies for early detection |
4.2.3 Growing investments in research and development for new treatment options |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of neurocutaneous syndromes among healthcare professionals and the general public in Israel |
4.3.2 High cost of treatment and lack of reimbursement options for some patients |
5 Israel Neurocutaneous Syndromes Market Trends |
6 Israel Neurocutaneous Syndromes Market, By Types |
6.1 Israel Neurocutaneous Syndromes Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Tuberous Sclerosis (TS), 2021- 2031F |
6.1.4 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Neurofibromatosis (NF), 2021- 2031F |
6.1.5 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Sturge-Weber Syndrome, 2021- 2031F |
6.1.6 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Ataxia-Telangiectasia (A-T), 2021- 2031F |
6.1.7 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Von Hippel-Lindau Disease (VHL), 2021- 2031F |
6.1.8 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Neurocutaneous Syndromes Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Skull Radiography, 2021- 2031F |
6.2.3 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.2.4 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Computed Tomography (CT) Scan, 2021- 2031F |
6.2.5 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Electroencephalogram (EEG), 2021- 2031F |
6.2.6 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Genetic Tests (Blood Testing), 2021- 2031F |
6.2.7 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.3 Israel Neurocutaneous Syndromes Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Laser Therapy, 2021- 2031F |
6.3.4 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Surgical Procedures, 2021- 2031F |
6.3.5 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Neurocutaneous Syndromes Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Hospitals And Clinics, 2021- 2031F |
6.4.3 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.4 Israel Neurocutaneous Syndromes Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neurocutaneous Syndromes Market Import-Export Trade Statistics |
7.1 Israel Neurocutaneous Syndromes Market Export to Major Countries |
7.2 Israel Neurocutaneous Syndromes Market Imports from Major Countries |
8 Israel Neurocutaneous Syndromes Market Key Performance Indicators |
8.1 Average age of diagnosis for neurocutaneous syndromes patients in Israel |
8.2 Number of clinical trials for neurocutaneous syndromes therapies conducted in Israel |
8.3 Rate of adoption of new diagnostic technologies in Israeli healthcare facilities |
9 Israel Neurocutaneous Syndromes Market - Opportunity Assessment |
9.1 Israel Neurocutaneous Syndromes Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Neurocutaneous Syndromes Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Neurocutaneous Syndromes Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Neurocutaneous Syndromes Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Neurocutaneous Syndromes Market - Competitive Landscape |
10.1 Israel Neurocutaneous Syndromes Market Revenue Share, By Companies, 2024 |
10.2 Israel Neurocutaneous Syndromes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here